UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:March 31,
ASLAN Pharmaceuticals (NASDAQ:ASLN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos ASLAN Pharmaceuticals.
ASLAN Pharmaceuticals (NASDAQ:ASLN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos ASLAN Pharmaceuticals.

Notícias Aslan Pharmaceuticals Ltd

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Sexta, 14 de Junho de 2024 (2 semanas atrás) • Edgar (US Regulatory)
Form F-3 - Registration statement by foreign private issuers
Quarta, 12 de Junho de 2024 (2 semanas atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Sexta, 31 de Maio de 2024 (4 semanas atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quinta, 9 de Maio de 2024 (2 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Terça, 7 de Maio de 2024 (2 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Segunda, 11 de Março de 2024 (4 meses atrás) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Quarta, 14 de Fevereiro de 2024 (4 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quarta, 24 de Janeiro de 2024 (5 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Segunda, 8 de Janeiro de 2024 (6 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Sexta, 22 de Dezembro de 2023 (6 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Sexta, 8 de Dezembro de 2023 (7 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Sexta, 27 de Outubro de 2023 (8 meses atrás) • Edgar (US Regulatory)

Mais Notícias de Aslan Pharmaceuticals Ltd